Correspondence re: G. C. de Gast et al., Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma. Clin. Cancer Res., 6: 1267-1272, 2000.
作者信息
Meyers F J, O' Donnell R T
出版信息
Clin Cancer Res. 2000 Oct;6(10):4167.
PMID:11051273
Abstract
摘要
Zotero 插件